what tirzepatide is approved for weight loss FDA approves Zepbound Retatrutide vs Tirzepatide: Which Weight-Loss

Data are available to request six months after the indication studied has been approved in the US and EU and after primary publication acceptance, whichever is later

The dose-response data supports targeting specific outcomes

No, you should not try to adjust the tirzepatide dosage on your own

Your first labs set a baseline before treatment begins

With respect to the primary endpoint of A1C reduction from baseline, dulaglutide 4.5 mg was superior to the 1.5 mg dose at Week 36 under the treatment regimen estimand (mean change from baseline [mean baseline 8.6%]: dulaglutide 1.5 mg -1.54%, dulaglutide 4.5 mg -1.77%